Atherosclerosis
Volume 209, Issue 1 , Pages 81-88 , March 2010

ADRP/ADFP and Mal1 expression are increased in macrophages treated with TLR agonists

  • Kenneth R. Feingold

      Affiliations

    • Metabolism Section, Department of Veterans Affairs Medical Center, San Francisco, CA, United States
    • Department of Medicine, University of California, San Francisco, CA, United States
    • Corresponding Author InformationCorresponding author at: SFVAMC – Metabolism Section, 4150 Clement Street, 111F, San Francisco, CA 94121, United States. Tel.: +1 415 750 2005; fax: +1 415 750 6927.
    • ,
  • Mahmood R. Kazemi

      Affiliations

    • Metabolism Section, Department of Veterans Affairs Medical Center, San Francisco, CA, United States
    • Department of Medicine, University of California, San Francisco, CA, United States
    • ,
  • Amy L. Magra

      Affiliations

    • National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States
    • ,
  • Carol M. McDonald

      Affiliations

    • Metabolism Section, Department of Veterans Affairs Medical Center, San Francisco, CA, United States
    • Department of Medicine, University of California, San Francisco, CA, United States
    • ,
  • Lisa G. Chui

      Affiliations

    • Metabolism Section, Department of Veterans Affairs Medical Center, San Francisco, CA, United States
    • Department of Medicine, University of California, San Francisco, CA, United States
    • ,
  • Judy K. Shigenaga

      Affiliations

    • Metabolism Section, Department of Veterans Affairs Medical Center, San Francisco, CA, United States
    • Department of Medicine, University of California, San Francisco, CA, United States
    • ,
  • Sophie M. Patzek

      Affiliations

    • Metabolism Section, Department of Veterans Affairs Medical Center, San Francisco, CA, United States
    • Department of Medicine, University of California, San Francisco, CA, United States
    • ,
  • Zoe W. Chan

      Affiliations

    • Metabolism Section, Department of Veterans Affairs Medical Center, San Francisco, CA, United States
    • Department of Medicine, University of California, San Francisco, CA, United States
    • ,
  • Constantine Londos

      Affiliations

    • National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States
    • ,
  • Carl Grunfeld

      Affiliations

    • Metabolism Section, Department of Veterans Affairs Medical Center, San Francisco, CA, United States
    • Department of Medicine, University of California, San Francisco, CA, United States

Received 9 June 2008 ,Revised 17 August 2009 ,Accepted 24 August 2009.

References 

  1. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340:115–126
  2. Epstein SE, Zhu J, Burnett MS, Zhou YF, Vercellotti G, Hajjar D. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol. 2000;20:1417–1420
  3. Kalayoglu MV, Libby P, Byrne GI. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA. 2002;288:2724–2731
  4. Laberge MA, Moore KJ, Freeman MW. Atherosclerosis and innate immune signalling. Ann Med. 2005;37:130–140
  5. Pussinen PJ, Mattila K. Periodontal infections and atherosclerosis: mere associations?. Curr Opin Lipidol. 2004;15:583–588
  6. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A. 1998;95:588–593
  7. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature. 2004;430:257–263
  8. Tobias P, Curtiss LK. Thematic review series: the immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis. J Lipid Res. 2005;46:404–411
  9. Kiechl S, Lorenz E, Reindl M, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med. 2002;347:185–192
  10. Pussinen PJ, Vilkuna-Rautiainen T, Alfthan G, et al. Severe periodontitis enhances macrophage activation via increased serum lipopolysaccharide. Arterioscler Thromb Vasc Biol. 2004;24:2174–2180
  11. Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol. 2000;164:558–561
  12. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006;116:3015–3025
  13. Miller YI, Chang MK, Binder CJ, Shaw PX, Witztum JL. Oxidized low density lipoprotein and innate immune receptors. Curr Opin Lipidol. 2003;14:437–445
  14. Xu XH, Shah PK, Faure E, et al. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation. 2001;104:3103–3108
  15. Oiknine J, Aviram M. Increased susceptibility to activation and increased uptake of low density lipoprotein by cholesterol-loaded macrophages. Arterioscler Thromb. 1992;12:745–753
  16. Funk JL, Feingold KR, Moser AH, Grunfeld C. Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation. Atherosclerosis. 1993;98:67–82
  17. Ostos MA, Recalde D, Zakin MM, Scott-Algara D. Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation. FEBS Lett. 2002;519:23–29
  18. Lehr HA, Sagban TA, Ihling C, et al. Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation. 2001;104:914–920
  19. Brasaemle DL, Barber T, Wolins NE, Serrero G, Blanchette-Mackie EJ, Londos C. Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein. J Lipid Res. 1997;38:2249–2263
  20. Magra AL, Mertz PS, Torday JS, Londos C. Role of adipose differentiation-related protein in lung surfactant production: a reassessment. J Lipid Res. 2006;47:2367–2373
  21. Robenek H, Robenek MJ, Buers I, et al. Lipid droplets gain PAT family proteins by interaction with specialized plasma membrane domains. J Biol Chem. 2005;280:26330–26338
  22. Robenek H, Robenek MJ, Troyer D. PAT family proteins pervade lipid droplet cores. J Lipid Res. 2005;46:1331–1338
  23. Wolins NE, Quaynor BK, Skinner JR, Schoenfish MJ, Tzekov A, Bickel PE. S3-12, adipophilin, and TIP47 package lipid in adipocytes. J Biol Chem. 2005;280:19146–19155
  24. Llorente-Cortes V, Royo T, Juan-Babot O, Badimon L. Adipocyte differentiation-related protein is induced by LRP1-mediated aggregated LDL internalization in human vascular smooth muscle cells and macrophages. J Lipid Res. 2007;48:2133–2140
  25. Larigauderie G, Furman C, Jaye M, et al. Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis. Arterioscler Thromb Vasc Biol. 2004;24:504–510
  26. Boord JB, Fazio S, Linton MF. Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol. 2002;13:141–147
  27. Kazemi MR, McDonald CM, Shigenaga JK, Grunfeld C, Feingold KR. Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists. Arterioscler Thromb Vasc Biol. 2005;25:1220–1224
  28. Krieg P, Feil S, Furstenberger G, Bowden GT. Tumor-specific overexpression of a novel keratinocyte lipid-binding protein. Identification and characterization of a cloned sequence activated during multistage carcinogenesis in mouse skin. J Biol Chem. 1993;268:17362–17369
  29. Makowski L, Boord JB, Maeda K, et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med. 2001;7:699–705
  30. Hertzel AV, Bernlohr DA. The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function. Trends Endocrinol Metab. 2000;11:175–180
  31. Scheja L, Makowski L, Uysal KT, et al. Altered insulin secretion associated with reduced lipolytic efficiency in aP2−/− mice. Diabetes. 1999;48:1987–1994
  32. Boord JB, Maeda K, Makowski L, et al. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. Circulation. 2004;110:1492–1498
  33. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 2001;13:85–94
  34. Zhang G, Ghosh S. Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through Toll-like receptors. J Endotoxin Res. 2000;6:453–457
  35. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem. 1994;269:5241–5248
  36. Cuenda A, Rouse J, Doza YN, et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 1995;364:229–233
  37. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem. 1995;270:27489–27494
  38. Noman AS, Koide N, Hassan F, et al. Thalidomide inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production via down-regulation of MyD88 expression. Innate Immun. 2009;15:33–41
  39. Gay NJ, Gangloff M. Structure and function of Toll receptors and their ligands. Annu Rev Biochem. 2007;76:141–165
  40. Gu JQ, Ikuyama S, Wei P, et al. Pycnogenol, an extract from French maritime pine, suppresses Toll-like receptor 4-mediated expression of adipose differentiation-related protein in macrophages. Am J Physiol Endocrinol Metab. 2008;295:E1390–E1400
  41. Werb Z, Chin JR. Endotoxin suppresses expression of apoprotein E by mouse macrophages in vivo and in culture. A biochemical and genetic study. J Biol Chem. 1983;258:10642–10648
  42. Baranova I, Vishnyakova T, Bocharov A, et al. Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells. Infect Immun. 2002;70:2995–3003
  43. Khovidhunkit W, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. Regulation of scavenger receptor class B type I in hamster liver and Hep3B cells by endotoxin and cytokines. J Lipid Res. 2001;42:1636–1644
  44. Khovidhunkit W, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. J Lipid Res. 2003;44:1728–1736
  45. Blessing E, Kuo CC, Lin TM, et al. Foam cell formation inhibits growth of Chlamydia pneumoniae but does not attenuate Chlamydia pneumoniae-induced secretion of proinflammatory cytokines. Circulation. 2002;105:1976–1982

PII: S0021-9150(09)00704-7

doi: 10.1016/j.atherosclerosis.2009.08.042

Atherosclerosis
Volume 209, Issue 1 , Pages 81-88 , March 2010

Article Tools

* Image Usage & Resolution